Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2012
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopyB Petritsch, H Köstler, W Machann, et al.
Neurology|May 29, 2003
Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoringG Buyse, L Mertens, G Di Salvo, et al.
Translational Psychiatry|July 27, 2012
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaF M Leweke, D Piomelli, F Pahlisch, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 17, 2003
The feasibility of ultrasonic regional strain and strain rate imaging in quantifying dobutamine stress echocardiographyM Kowalski, M-C Herregods, L Herbots, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 6, 2011
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart FailureC Zugck, J Franke, G Gelbrich, et al.
Circulation|September 12, 2001
Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunctionT M Behr, S S Nerurkar, A H Nelson, et al.
Cancer Research|September 1, 1983
Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chainM I Bernhard, K A Foon, T N Oeltmann, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Pageof 13